Cellectis (CLLS) Total Liabilities (2013 - 2026)

Cellectis' Total Liabilities history runs 14 years deep, the most recent figure standing at $229.3 million for Q1 2026.

• In Q1 2026, Total Liabilities fell 7.51% year-over-year to $229.3 million; the TTM figure through Mar 2026 stood at $229.3 million (down 7.51% YoY), while the FY2025 annual figure was $248.8 million, down 1.46% from the prior year.
• Total Liabilities for Q1 2026 stood at $229.3 million, down from $248.8 million in the prior quarter.
• The five-year high for Total Liabilities was $320.9 million in Q2 2022, with the low at $15.2 million in Q4 2022.
• The 5-year median for Total Liabilities is $249.6 million (2023), against an average of $226.1 million.
• The sharpest annual moves came in 2022 and 2023: Total Liabilities plunged 94.71% in 2022, then soared 1543.24% in 2023.
• Cellectis' Total Liabilities stood at $15.2 million in 2022, then soared by 1543.24% to $249.6 million in 2023, then advanced by 1.18% to $252.5 million in 2024, then dropped by 1.46% to $248.8 million in 2025, then decreased by 7.86% to $229.3 million in 2026.
• Business Quant data shows CLLS's Total Liabilities at $229.3 million in Q1 2026, $248.8 million in Q4 2025, and $242.6 million in Q3 2025.